AR082472A1 - Compuestos con actividad antibacteriana contra clostridium - Google Patents

Compuestos con actividad antibacteriana contra clostridium

Info

Publication number
AR082472A1
AR082472A1 ARP110102808A ARP110102808A AR082472A1 AR 082472 A1 AR082472 A1 AR 082472A1 AR P110102808 A ARP110102808 A AR P110102808A AR P110102808 A ARP110102808 A AR P110102808A AR 082472 A1 AR082472 A1 AR 082472A1
Authority
AR
Argentina
Prior art keywords
compounds
alkyl
hydrogen
hydroxy
activity against
Prior art date
Application number
ARP110102808A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR082472A1 publication Critical patent/AR082472A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compuestos que tienen actividad anti bacteriana contra bacteria Clostridium, en particular Clostridium perfringens, composiciones farmacéuticas que comprenden estos compuestos, y procesos químicos para preparar estos compuestos.Reivindicación 1: Un compuesto de fórmula (1) incluyendo cualquier forma estereoquímicamente isomérica y tautómero del mismo, donde R1 y R2 son cada uno de manera independiente seleccionados entre hidrógeno, halo, hidroxi, alquilo C1-6, polihaloalquilo C1-6, alquiloxi C1-6, o polihaloalquiloxi C1-6; R3 es hidroxi, amino, mono- o di(alquil C1-4)amino; R4 es hidrógeno o alquilo C1-4; X es nitrógeno o CR5 donde R5 es hidrógeno, halo o alquilo C1-4; siempre que cuando R3 sea hidroxi entonces X represente CH y R4 represente hidrógeno; o una sal de adición ácida farmacéuticamente aceptable del mismo, o un solvato del mismo.
ARP110102808A 2010-08-04 2011-08-03 Compuestos con actividad antibacteriana contra clostridium AR082472A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10171842 2010-08-04

Publications (1)

Publication Number Publication Date
AR082472A1 true AR082472A1 (es) 2012-12-12

Family

ID=43125618

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110102808A AR082472A1 (es) 2010-08-04 2011-08-03 Compuestos con actividad antibacteriana contra clostridium

Country Status (28)

Country Link
US (1) US8618100B2 (es)
EP (1) EP2601193B1 (es)
JP (1) JP5886285B2 (es)
KR (1) KR101499368B1 (es)
CN (1) CN103038234B (es)
AR (1) AR082472A1 (es)
AU (1) AU2011287584B2 (es)
BR (1) BR112013003675A8 (es)
CA (1) CA2805358C (es)
CL (1) CL2013000331A1 (es)
CO (1) CO6680629A2 (es)
CY (1) CY1116238T1 (es)
DK (1) DK2601193T3 (es)
EA (1) EA021567B1 (es)
ES (1) ES2538998T3 (es)
HK (1) HK1180690A1 (es)
HR (1) HRP20150467T1 (es)
ME (1) ME02061B (es)
MX (1) MX2013001246A (es)
NZ (1) NZ605850A (es)
PL (1) PL2601193T3 (es)
PT (1) PT2601193E (es)
RS (1) RS53990B1 (es)
SG (1) SG187175A1 (es)
SI (1) SI2601193T1 (es)
TW (1) TWI498330B (es)
WO (1) WO2012017030A1 (es)
ZA (1) ZA201300432B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
WO2016127102A2 (en) * 2015-02-06 2016-08-11 Ernesto Abel-Santos Inhibiting germination of clostridium perfringens spores to reduce necrotic enteritis
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
KR101769204B1 (ko) * 2015-08-04 2017-08-17 씨제이헬스케어 주식회사 크로마놀 유도체의 신규한 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5247705B2 (ja) * 2006-09-26 2013-07-24 クレストーン・インコーポレーテッド 抗細菌活性を持つ置換チエノピリドン化合物
EP2091536B1 (en) * 2006-09-26 2013-07-31 Crestone, Inc. Enantiomeric compounds with antibacterial activity
WO2008039642A2 (en) * 2006-09-26 2008-04-03 Replidyne, Inc. Methods and compounds for treatment of clostridium based infection

Also Published As

Publication number Publication date
PT2601193E (pt) 2015-05-18
DK2601193T3 (en) 2015-03-23
ME02061B (me) 2015-05-20
TWI498330B (zh) 2015-09-01
WO2012017030A1 (en) 2012-02-09
JP2013532714A (ja) 2013-08-19
TW201211048A (en) 2012-03-16
CL2013000331A1 (es) 2013-06-28
EP2601193A1 (en) 2013-06-12
HK1180690A1 (en) 2013-10-25
CA2805358C (en) 2016-02-16
HRP20150467T1 (hr) 2015-06-05
NZ605850A (en) 2014-07-25
MX2013001246A (es) 2013-03-21
AU2011287584A1 (en) 2013-02-07
ZA201300432B (en) 2014-08-27
PL2601193T3 (pl) 2015-08-31
US20130109694A1 (en) 2013-05-02
KR101499368B1 (ko) 2015-03-05
KR20130033440A (ko) 2013-04-03
RS53990B1 (en) 2015-10-30
BR112013003675A8 (pt) 2017-12-26
AU2011287584B2 (en) 2014-05-01
CA2805358A1 (en) 2012-02-09
SG187175A1 (en) 2013-02-28
JP5886285B2 (ja) 2016-03-16
CO6680629A2 (es) 2013-05-31
BR112013003675A2 (pt) 2016-09-06
EA021567B1 (ru) 2015-07-30
ES2538998T3 (es) 2015-06-25
US8618100B2 (en) 2013-12-31
CY1116238T1 (el) 2017-02-08
EP2601193B1 (en) 2015-03-11
EA201270817A1 (ru) 2013-05-30
CN103038234A (zh) 2013-04-10
SI2601193T1 (sl) 2015-05-29
CN103038234B (zh) 2016-02-24

Similar Documents

Publication Publication Date Title
PH12017501192B1 (en) Certain amino-pyridazines, compositions thereof, and methods of their use
PH12016502037A1 (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
PH12014502597A1 (en) N-substituted benzamides and their use in the treatment of pain
MX2015010775A (es) Benzoxazoles sustituidos y metodos para usarlos.
MX2015011436A (es) Triazolopiridinas sustituidas y metodos para usarlas.
MX2016006336A (es) Compuestos pirazolopirimidina.
NZ723198A (en) Anthelmintic compounds and compositions and methods of using thereof
MD4556C1 (ro) Compuşi inhibitori ai activităţii catehol O-metiltransferazei
MY186599A (en) Substituted pyridopyrazines as novel syk inhibitors
MX348084B (es) Compuestos de cetolido.
NZ596628A (en) Ketolide compounds having antimicrobial activity
AR074833A1 (es) Agentes lipopeptidicos antibacterianos para el tratamiento de infecciones con grampositivos
MX363478B (es) 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas.
PH12015501175A1 (en) Substituted pyridopyrazines as syk inhibitors
UA111210C2 (uk) Антибактеріальні 3,4-дигідро-1h-[1,8]нафтиридинони, заміщені циклопента[c]піролом
PH12018502012A1 (en) Griseofulvin compound
PH12015502429A1 (en) Dicarboxylic acid compound
PH12014502285A1 (en) Anti-malarial agents
AR082472A1 (es) Compuestos con actividad antibacteriana contra clostridium
MX2015001834A (es) Nuevos compuestos antibacterianos.
MX2015001835A (es) Nuevos compuestos antibacterianos.
IN2014MN02433A (es)
MX2015017864A (es) Metodo de preparacion de derivados de acido pirrolidina-2-carboxil ico.
PH12015502060A1 (en) Hydrochloride salts of an antibiotic compound
TN2013000150A1 (en) Co-crystals and salts of ccr3-inhibitors

Legal Events

Date Code Title Description
FB Suspension of granting procedure